2013
DOI: 10.1111/pcn.12040
|View full text |Cite
|
Sign up to set email alerts
|

Is T‐helper type 2 shift schizophrenia‐specific? Primary results from a comparison of related psychiatric disorders and healthy controls

Abstract: Aim: An imbalance between T-helper type 1 (Th1) and type 2 (Th2) cytokines has been implicated in schizophrenia, although empirical evidence is rare. The aim of this study was to examine if a Th1/Th2 imbalance occurs in schizophrenia and schizophrenia-related disorder.Methods: Twenty-six subjects with schizophrenia, 26 subjects with schizophrenia-related disorders, and 26 healthy controls were recruited. The Human Th1/Th2 Cytokine Cytometric Bead Array Kit-II was utilized to assess serum Th1/Th2 cytokines and … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
13
0

Year Published

2014
2014
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 30 publications
(14 citation statements)
references
References 44 publications
1
13
0
Order By: Relevance
“…Our findings of elevated levels of TNF-α and IL-6 in schizophrenia are consistent with some studies, (15, 2029, 3539, 44, 4762), but not others (20, 21, 23, 26, 30–45, 6368, 7881). We did not find a significant difference in IFN-γ levels between schizophrenia and HC groups, similar to several published studies (38, 67, 7881). Only one study that reported lower IFN-γ levels in persons with schizophrenia than in HCs had more than 50 subjects in each group, but had limited generalizability as all the study participants were men and smoked fewer than 5 cigarettes per day (44).…”
Section: Discussionsupporting
confidence: 93%
See 2 more Smart Citations
“…Our findings of elevated levels of TNF-α and IL-6 in schizophrenia are consistent with some studies, (15, 2029, 3539, 44, 4762), but not others (20, 21, 23, 26, 30–45, 6368, 7881). We did not find a significant difference in IFN-γ levels between schizophrenia and HC groups, similar to several published studies (38, 67, 7881). Only one study that reported lower IFN-γ levels in persons with schizophrenia than in HCs had more than 50 subjects in each group, but had limited generalizability as all the study participants were men and smoked fewer than 5 cigarettes per day (44).…”
Section: Discussionsupporting
confidence: 93%
“…IFN-γ is involved in lymphocyte activation and the kynurenine pathway of tryptophan metabolism, which may link inflammatory processes with glutamatergic and dopaminergic systems. Nine studies of IFN-γ reported lower levels (24, 44, 6975), four found higher levels (29, 37, 76, 77), and six showed no difference in levels (38, 67, 7881). …”
Section: Objectivementioning
confidence: 98%
See 1 more Smart Citation
“…Since IDO and KMO expression appear to be positively regulated by similar mechanisms, it would be interesting to determine whether KMO expression is similarly inhibited by IL-4 and/or IL-13, and whether such inhibition leads to overproduction of central KYNA. Such a hypothesis might be relevant to a role of cytokine-mediated KP dysregulation in schizophrenia, since a recent study of 26 schizophrenic patients and 26 control subjects found that the ratios of serum IFN-γ/IL-4, IFN-γ/IL-10, IL-2/IL-4, and TNF-α/IL-4 were significantly reduced in schizophrenic patients compared to controls (Chiang et al, 2013). These data support an emerging, though controversial hypothesis which proposes that schizophrenia is associated with a subtle shift from the production of Th1 cytokines, such as IFN-γ, IL-2, and TNF-α, toward the production of Th2 cytokines, such as IL-4, IL-10, and IL-6 [reviewed in Muller et al (2012)].…”
Section: Dysregulation Of the Kynurenine Pathway In Cns Diseasesmentioning
confidence: 99%
“…Results are highly agreeable with a large bulk of studies with variable respects to the clinical stage of the disease and status of medical treatment or associated other parameters, among these Potvin et al, (19) later psychiatric assessments ,they concluded that higher levels of the systemic inflammatory marker IL-6 in childhood are associated with an increased risk of developing schizophrenia in young adulthood. Chiang et al, (20) found that the IL6 level in schizophrenic patient, and control subjects were not significantly distinguishable P= 0.93. On the other hand serum IL10 showed only a marginal and statistically insignificant increase P=0.74, in cases with schizophrenia mean 322.3pg/ml when compared to both healthy and relative groups (mean 310.8 and 302.5 pg/ml) respectively P=0.74.…”
Section: Discussionmentioning
confidence: 99%